Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Jan 27, 2021
Date Accepted: Oct 28, 2021
Date Submitted to PubMed: Dec 3, 2021
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Selecting and Evaluating Mobile Health Apps for the Healthy Life Trajectories Initiative (HeLTI): A Practical and Pragmatic Approach
ABSTRACT
The ubiquity of smartphones and mobile devices in the general population presents an unprecedented opportunity for preventative health. Not surprisingly, the use of electronic health resources (i.e., eHealth resources) accessed through mobile devices in clinical trials is becoming more prevalent; the selection, screening, and collation of quality eHealth resources is necessary to clinical trials using these technologies. However, the constant creation and turnover of new eHealth resources can make this task difficult. There may be value in adopting practical and pragmatic approaches to helping researchers and clinicians identify and disseminate e-resources. The study aimed to create a set of guidelines (i.e., a checklist) to aid the members of the Healthy Life Trajectories Initiative (HeLTI) Canada trial – a preconception randomized controlled clinical trial to prevent child obesity – to assist their efforts in searching, identifying, screening, and including selected eHealth resources for participant use in the study intervention. This checklist may be useful to other researchers and practitioners developing similar interventions.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.